Pandey AV - Search Results

1

Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency.

Flück CE, Mallet D, Hofer G, Samara-Boustani D, Leger J, Polak M, Morel Y, Pandey AV. Flück CE, et al. Among authors: pandey av. Biochem Biophys Res Commun. 2011 Sep 9;412(4):572-7. doi: 10.1016/j.bbrc.2011.08.001. Epub 2011 Aug 6. Biochem Biophys Res Commun. 2011. PMID: 21843508

2

Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome.

Flück CE, Tajima T, Pandey AV, Arlt W, Okuhara K, Verge CF, Jabs EW, Mendonça BB, Fujieda K, Miller WL. Flück CE, et al. Among authors: pandey av. Nat Genet. 2004 Mar;36(3):228-30. doi: 10.1038/ng1300. Epub 2004 Feb 1. Nat Genet. 2004. PMID: 14758361

3

P450 oxidoreductase deficiency.

Miller WL, Huang N, Flück CE, Pandey AV. Miller WL, et al. Among authors: pandey av. Lancet. 2004 Nov 6-12;364(9446):1663. doi: 10.1016/S0140-6736(04)17344-3. Lancet. 2004. PMID: 15530620 No abstract available.

4

P450 oxidoreductase deficiency: a new disorder of steroidogenesis affecting all microsomal P450 enzymes.

Pandey AV, Flück CE, Huang N, Tajima T, Fujieda K, Miller WL. Pandey AV, et al. Endocr Res. 2004 Nov;30(4):881-8. doi: 10.1081/erc-200044134. Endocr Res. 2004. PMID: 15666840

5

Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.

Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, Jabs EW, Van Vliet G, Sack J, Flück CE, Miller WL. Huang N, et al. Among authors: pandey av. Am J Hum Genet. 2005 May;76(5):729-49. doi: 10.1086/429417. Epub 2005 Mar 25. Am J Hum Genet. 2005. PMID: 15793702 Free PMC article.

6

P450 oxidoreductase deficiency: a new disorder of steroidogenesis.

Miller WL, Huang N, Pandey AV, Flück CE, Agrawal V. Miller WL, et al. Among authors: pandey av. Ann N Y Acad Sci. 2005 Dec;1061:100-8. doi: 10.1196/annals.1336.012. Ann N Y Acad Sci. 2005. PMID: 16467261 Review.

7

Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein.

Janner M, Pandey AV, Mullis PE, Flück CE. Janner M, et al. Among authors: pandey av. Eur J Endocrinol. 2006 Jul;155(1):143-51. doi: 10.1530/eje.1.02172. Eur J Endocrinol. 2006. PMID: 16793961

8

Biochemical analysis of mutations in P450 oxidoreductase.

Pandey AV. Pandey AV. Biochem Soc Trans. 2006 Dec;34(Pt 6):1186-91. doi: 10.1042/BST0341186. Biochem Soc Trans. 2006. PMID: 17073782

9

Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase.

Pandey AV, Kempná P, Hofer G, Mullis PE, Flück CE. Pandey AV, et al. Mol Endocrinol. 2007 Oct;21(10):2579-95. doi: 10.1210/me.2007-0245. Epub 2007 Jun 26. Mol Endocrinol. 2007. PMID: 17595315

10

The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.

Pepe CM, Saraco NI, Baquedano MS, Guercio G, Vaiani E, Marino R, Pandey AV, Flück CE, Rivarola MA, Belgorosky A. Pepe CM, et al. Among authors: pandey av. Clin Endocrinol (Oxf). 2007 Nov;67(5):698-705. doi: 10.1111/j.1365-2265.2007.02948.x. Epub 2007 Jul 2. Clin Endocrinol (Oxf). 2007. PMID: 17608756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters